S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
66,000% upside on tiny biotech? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
66,000% upside on tiny biotech? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
66,000% upside on tiny biotech? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
66,000% upside on tiny biotech? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
66,000% upside on tiny biotech? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
66,000% upside on tiny biotech? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
66,000% upside on tiny biotech? (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
66,000% upside on tiny biotech? (Ad)
Grant program for Black women entrepreneurs blocked by federal appeals court
Donald Trump says he will be in courtroom for New York trial scrutinizing his business practices
ETR:FME

Fresenius Medical Care AG & Co. KGaA (FME) Price Target & Analyst Ratings

€40.84
-0.16 (-0.39%)
(As of 09/29/2023 ET)
Compare
Today's Range
€40.73
▼
€41.81
50-Day Range
€39.70
▼
€48.86
52-Week Range
€25.95
▼
€49.62
Volume
544,011 shs
Average Volume
704,197 shs
Market Capitalization
$11.98 billion
P/E Ratio
20.12
Dividend Yield
2.74%
Price Target
€30.19
ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesSustainability

Fresenius Medical Care AG & Co. KGaA Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

€30.19
High Prediction€46.83
Average Prediction€30.19
Low Prediction€17.10
TypeCurrent
10/1/22 to 10/1/23		1 Month Ago
9/1/22 to 9/1/23		3 Months Ago
7/3/22 to 7/3/23		1 Year Ago
10/1/21 to 10/1/22
Consensus RatingN/AN/AN/AN/A
Strong Buy N/A N/A N/A N/A
Buy N/A N/A N/A N/A
Hold N/A N/A N/A N/A
Sell N/A N/A N/A N/A
Consensus Price Target€30.19€30.19€30.19€52.15
Get Fresenius Medical Care AG & Co. KGaA Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter.


FME Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

FME Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Fresenius Medical Care AG & Co. KGaA Stock vs. The Competition

TypeFresenius Medical Care AG & Co. KGaAMedical Companies
Consensus Rating Score
0.00
2.66
Consensus RatingN/AModerate Buy
News Sentiment RatingPositive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/14/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		James Vane-Tempest
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€21.00-43.40%
3/14/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Christoph Gretler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€35.00-5.66%
3/9/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Falko Friedrichs
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€23.00-36.48%
3/8/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Victoria Lambert
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€46.83+29.54%
3/7/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Rajesh Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€33.00-12.09%
3/6/2023Warburg Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Christian Ehmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€22.00-40.05%
2/28/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Graham Doyle
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€38.00-0.52%
2/22/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Hassan Al-Wakeel
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€32.00-13.89%
2/20/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		David Adlington
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€17.10-54.36%
10/18/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Robert Davies
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target€34.00+23.01%
(Data available from 10/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












FME Price Target - Frequently Asked Questions

Does Fresenius Medical Care AG & Co. KGaA's stock price have much downside?

According to analysts, Fresenius Medical Care AG & Co. KGaA's stock has a predicted downside of -16.43% based on their 12-month price targets.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (ETR:FME) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -